A detailed history of Allspring Global Investments Holdings, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 24,263 shares of AMPH stock, worth $882,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,263
Previous 40,946 40.74%
Holding current value
$882,930
Previous $1.64 Million 28.1%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$36.99 - $50.09 $617,104 - $835,651
-16,683 Reduced 40.74%
24,263 $1.18 Million
Q2 2024

Jul 26, 2024

SELL
$38.65 - $43.48 $912,835 - $1.03 Million
-23,618 Reduced 36.58%
40,946 $1.64 Million
Q1 2024

Apr 18, 2024

BUY
$42.85 - $63.45 $1.06 Million - $1.57 Million
24,678 Added 61.87%
64,564 $2.84 Million
Q4 2023

Jan 25, 2024

BUY
$44.49 - $62.93 $1.46 Million - $2.07 Million
32,850 Added 466.88%
39,886 $2.47 Million
Q3 2023

Oct 27, 2023

BUY
$45.51 - $65.0 $320,208 - $457,340
7,036 New
7,036 $323,000
Q2 2023

Jul 18, 2023

SELL
$35.77 - $58.38 $3.37 Million - $5.49 Million
-94,091 Reduced 94.05%
5,954 $342,000
Q1 2023

Apr 13, 2023

SELL
$27.99 - $37.92 $288,856 - $391,334
-10,320 Reduced 9.35%
100,045 $3.75 Million
Q4 2022

Jan 23, 2023

SELL
$27.93 - $31.27 $3.24 Million - $3.63 Million
-116,159 Reduced 51.28%
110,365 $0
Q3 2022

Oct 26, 2022

BUY
$27.56 - $37.75 $4.62 Million - $6.32 Million
167,471 Added 283.59%
226,524 $6.37 Million
Q2 2022

Jul 25, 2022

SELL
$29.79 - $42.29 $685,170 - $972,670
-23,000 Reduced 28.03%
59,053 $2.05 Million
Q1 2022

May 02, 2022

SELL
$22.96 - $36.45 $3.9 Million - $6.19 Million
-169,908 Reduced 67.43%
82,053 $2.95 Million
Q4 2021

Jan 28, 2022

BUY
$18.14 - $23.29 $4.57 Million - $5.87 Million
251,961 New
251,961 $5.87 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.78B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.